APTEVO THERAPEUTICS INC's ticker is APVO and the CUSIP is 03835L108. A total of 56 filers reported holding APTEVO THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $51,000 | +45.7% | 78,456 | +32.0% | 0.00% | – |
| Q3 2019 | $35,000 | -34.0% | 59,439 | 0.0% | 0.00% | – |
| Q2 2019 | $53,000 | -1.9% | 59,439 | -1.4% | 0.00% | – |
| Q1 2019 | $54,000 | -37.9% | 60,259 | -12.2% | 0.00% | – |
| Q4 2018 | $87,000 | -75.6% | 68,600 | -2.0% | 0.00% | – |
| Q3 2018 | $356,000 | +1.1% | 70,003 | -0.6% | 0.00% | – |
| Q2 2018 | $352,000 | +85.3% | 70,416 | +21.2% | 0.00% | – |
| Q1 2018 | $190,000 | -19.1% | 58,117 | +4.9% | 0.00% | – |
| Q4 2017 | $235,000 | +95.8% | 55,399 | +5.6% | 0.00% | – |
| Q3 2017 | $120,000 | +10.1% | 52,460 | -0.6% | 0.00% | – |
| Q2 2017 | $109,000 | -73.3% | 52,774 | -73.4% | 0.00% | – |
| Q1 2017 | $408,000 | -20.5% | 198,268 | -5.7% | 0.00% | – |
| Q4 2016 | $513,000 | -13.5% | 210,178 | -9.3% | 0.00% | – |
| Q3 2016 | $593,000 | – | 231,846 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HighVista Strategies LLC | 196,600 | $981,000 | 0.44% |
| Sessa Capital IM, L.P. | 519,894 | $2,594,000 | 0.26% |
| Alambic Investment Management, L.P. | 116,427 | $581,000 | 0.16% |
| Park West Asset Management LLC | 500,000 | $2,495,000 | 0.09% |
| EAM Investors, LLC | 110,584 | $552,000 | 0.09% |
| ATLAS CAPITAL ADVISORS LLC | 49,045 | $232,473,000 | 0.08% |
| Spark Investment Management LLC | 135,600 | $676,000 | 0.04% |
| CSS LLC/IL | 118,736 | $592,000 | 0.03% |
| OXFORD ASSET MANAGEMENT LLP | 172,639 | $874,000 | 0.02% |
| SFMG, LLC | 15,544 | $78,000 | 0.01% |